INSCoV-614 (1B)
INSCoV-614 (1B) is a potent inhibitor of Mpro (3CLpro) . Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-614 (1B) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) [1].
Product Specifications
CAS Number
[2735704-33-1]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/inscov-614-1b.html
Solubility
10 mM in DMSO
Smiles
Cl[C@H](F)C(N(C1=CC=C(C2=CC=NO2)C=C1)[C@@H](C3=CN=CN=C3)C(NC4CCC(F)(CC4)F)=O)=O
Molecular Formula
C23H21ClF3N5O3
Molecular Weight
507.89
References & Citations
[1]Aleksandrs Zavoronkovs, et al. Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections. Patent WO2021219089A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human ZNF778 sgRNA gene knockout kit - Lentiviral human ZNF778 sgRNA gene knockout kit (100)
Lentiviral mouse Arhgef12 shRNA (UAS) - Lentiviral mouse Arhgef12 shRNA (UAS, GFP) (100)